The Latest in Lymphoma & Plasma Cell Disorders

Therapy granted PIM designation for CTCL

February 3, 2017

Regimens seem similarly effective in ENKTL

February 2, 2017

Company withdraws MAA for pegfilgrastim biosimilar

February 2, 2017

Cheap manufacture of generic cancer drugs is feasible, study shows

February 2, 2017

Group proposes new prognostic model for PTCL-NOS

February 1, 2017

Project provides insight into T-cell lymphoma

February 1, 2017

Recent price hikes for generic cancer meds exceed 100%

February 1, 2017

Brentuximab vedotin bests standard of care in CTCL

January 31, 2017

Study provides new insight into B-cell metabolism

January 29, 2017

Combo granted orphan designation for DLBCL

January 27, 2017

Study quantifies 5-year survival rates for blood cancers

January 25, 2017

Improving the efficacy of obinutuzumab

January 24, 2017

Overcoming glucocorticoid resistance in lymphoma

January 23, 2017

FDA approves ibrutinib to treat rel/ref MZL

January 20, 2017

Prolonged work-related stress linked to NHL, other cancers in men

January 19, 2017